This research group focuses on applying epidemiological methods to evaluate the burden of autism spectrum disorder (ASD) on Qatari families and other families residing in Qatar, through studying the prevalence rates of ASD and all contributing risk factors associated with the disorder.

The group is also working to establish the first ASD registry in Qatar and to develop innovative early diagnostic and screening tools using eye tracking technology in collaboration with Cleveland Clinic. In addition, to establish the first Arabic Digital phenotyping for social communication behaviors, as a diagnostic tool for autism, using machine learning and artificial intelligence in collaboration with Argus Cognitive, USA.

The group is committed to establishing a regional center of autism research excellence that will contribute to improving early diagnosis, intervention, and treatment of autism spectrum disorders. The group plans to achieve this through the development of interdisciplinary research programs, one of which focused on ASD prevalence rate and its contributing risk factors associated with the disorder in Qatar. This ambitious Qatar National Research Fund (QNRF) funded research project was executed in collaboration with Qatar-based entities such as; Hamad Medical Corporation, Qatar University, and Shafallah Center for Children with Special needs, and international research institutions, including Cleveland Clinic and Oregon Health and Science University in the USA.